Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-21-024985
Date:2021-06-17
Issuer: GLOBAL BLOOD THERAPEUTICS, INC. (GBT)
Original Submission Date:

Reporting Person:

PERRY MARK L
C/O GLOBAL BLOOD THERAPEUTICS, INC.
181 OYSTER POINT BLVD. SOUTH SAN FRANCISCO, CA 94080

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2021-06-17 M 3,037 a $0.00 34,265 direct
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2021-06-17 deemed execution date M 3,037 (d) 2021-06-17 common stock 3,037 $0.00 0 direct
STOCK OPTION (RIGHT TO BUY) 37.09 2021-06-17 deemed execution date A 5,600 (a) 2031-06-16 common stock 5,600 $37.09 5,600 direct
RESTRICTED STOCK UNITS 0.0 2021-06-17 deemed execution date A 3,600 (a) common stock 3,600 $0.00 3,600 direct
Footnotes
IDfootnote
f1 each restricted stock unit ("rsu") represents a contingent right to receive one share of the issuer's common stock.
f2 the rsus vested in a single installment on june 17, 2021.
f3 the shares subject to this option shall vest and become exercisable in equal monthly installments over a period of 12 months following june 17, 2021 for 11 months and the remaining 1/12th on the earlier of (i) june 17, 2022 or (ii) the issuer's next annual meeting of stockholders, in each case subject to the reporting person's continued service on the issuer's board of directors. this option is subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a sale event (as defined in the issuer's 2015 stock option and incentive plan, as amended).
f4 the shares of common stock underlying the rsus vest in a single installment on the earlier of (i) june 17, 2022 or (ii) the issuer's next annual meeting of stockholders, in each case subject to the reporting person's continued service on the issuer's board of directors. the shares of common stock underlying the rsus are subject to full acceleration of vesting with respect to all then-unvested shares upon the consummation of a sale event (as defined in the issuer's 2015 stock option and incentive plan, as amended).

Elevate your investments